A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MLCP / MLC phosphatase

[Related PubMed/MEDLINE]
Total Number of Papers: 36
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MLCP  (>> Co-occurring Abbreviation)
Long Form:   MLC phosphatase
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 Identification of the Kinase-Substrate Recognition Interface between MYPT1 and Rho-Kinase. DMs, MLC, MYPT1, PS
2021 Mechanism of alpha1-Adrenergic Receptor-Induced Increased Contraction of Rat Mesenteric Artery in Aging Hypertension Rats. alpha1-AR, CPI-17, MLC, MLCK, PE, PKC, SHRs, WKY
2021 mTOR Inhibition Promotes Pneumonitis through Inducing Endothelial Contraction and Hyperpermeability. EC, MLC, MLCK, mTORi
2019 (-)-Epicatechin and NADPH oxidase inhibitors prevent bile acid-induced Caco-2 monolayer permeabilization through ERK1/2 modulation. DCA, EC, GI, MLC
2018 Mechanistic studies of a cell-permeant peptide designed to enhance myosin light chain phosphorylation in polarized intestinal epithelia. CPI-17, CPP, MLC, PP1, TJ
2017 cGMP signaling inhibits platelet shape change through regulation of the RhoA-Rho Kinase-MLC phosphatase signaling pathway. MLC, NO, PKG, thr853
2017 Differential mechanisms of adenosine- and ATPgammaS-induced microvascular endothelial barrier strengthening. ADO, ATPgammaS, cAMP, EC, HLMVEC, MLC20, PKA
2017 Mechanisms underlying the pathogenesis of hyper-contractility of bronchial smooth muscle in allergic asthma. AHR, BSM, IL-13, MLC, TNF-alpha
2016 All-Trans Retinoic Acid Inhibits Human Colorectal Cancer Cells RKO Migration via Downregulating Myosin Light Chain Kinase Expression through MAPK Signaling Pathway. ATRA, ERK, MLCK, mRNA, PMA, ZO-1
10  2016 The protective role of MLCP-mediated ERM dephosphorylation in endotoxin-induced lung injury in vitro and in vivo. ALI, C/A
11  2015 Inhibition of RhoA-dependent pathway and contraction by endogenous hydrogen sulfide in rabbit gastric smooth muscle cells. CBS, CSE, MLC, MLC20, PPG
12  2014 Rac1 regulates myosin II phosphorylation through regulation of myosin light chain phosphatase. PKC
13  2014 Rho-kinase signaling controls nucleocytoplasmic shuttling of class IIa histone deacetylase (HDAC7) and transcriptional activation of orphan nuclear receptor NR4A1. MLC, MLCK, OPHN1
14  2013 cAMP signaling regulates platelet myosin light chain (MLC) phosphorylation and shape change through targeting the RhoA-Rho kinase-MLC phosphatase signaling pathway. cAMP, MLC, MYPT1, PGE1, PKA, PP1delta, ROCK
15  2013 Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase-signaling pathways. MLCK, ox-LDL
16  2012 Decreased myosin phosphatase target subunit 1(MYPT1) phosphorylation via attenuated rho kinase and zipper-interacting kinase activities in edematous intestinal smooth muscle. MLC, MLCK, MYPT1
17  2012 Direct binding and regulation of RhoA protein by cyclic GMP-dependent protein kinase Ialpha. cGMP, MLC, VSMC
18  2012 Measurement of cytosolic Ca2+ in isolated contractile lymphatics. MLC
19  2011 A role for zinc in regulating hypoxia-induced contractile events in pulmonary endothelium. MLC, TPEN
20  2011 Molecular characterization of myosin phosphatase in endothelium. C/A, EC, HPAEC, MLC, MYPT1
21  2010 Cellular mechanisms underlying nitric oxide-induced vasodilation of descending vasa recta. DVR, MLC, NO
22  2010 Heart-specific small subunit of myosin light chain phosphatase activates rho-associated kinase and regulates phosphorylation of myosin phosphatase target subunit 1. MLC, ROCK
23  2010 Modulation of smooth muscle tonus in the lower urinary tract: interplay of myosin light-chain kinase (MLCK) and MLC phosphatase (MLCP). GAPDH, MLCK
24  2010 Vascular Smooth Muscle Cell Signaling Mechanisms for Contraction to Angiotensin II and Endothelin-1. DAG, MLC, NSCC, PKC, PLC, ROC
25  2009 Volatile anesthetics inhibit angiotensin II-induced vascular contraction by modulating myosin light chain phosphatase inhibiting protein, CPI-17 and regulatory subunit, MYPT1 phosphorylation. Ang II, MLC, PKC
26  2007 A novel regulatory mechanism of myosin light chain phosphorylation via binding of 14-3-3 to myosin phosphatase. EGF, MLC
27  2007 cGMP-dependent relaxation of smooth muscle is coupled with the change in the phosphorylation of myosin phosphatase. MBS, MLC
28  2007 Extracellular ATP induces assembly and activation of the myosin light chain phosphatase complex in endothelial cells. MLC, PP1
29  2007 MLC-kinase/phosphatase control of Ca2+ signal transduction in airway smooth muscles. CaM, MLC, MLCK
30  2007 Theoretical and experimental investigation of calcium-contraction coupling in airway smooth muscle. MLC, MLCK
31  2006 Agonist- and depolarization-induced signals for myosin light chain phosphorylation and force generation of cultured vascular smooth muscle cells. MLC, VSMCs
32  2006 Ca2+-desensitizing hypoxic vasorelaxation: pivotal role for the myosin binding subunit of myosin phosphatase (MYPT1) in porcine coronary artery. p-MYPT1, PCASM
33  2006 RhoA/Rho-kinase in erectile tissue: mechanisms of disease and therapeutic insights. MLC
34  2004 Inhibition of protein kinase C-mediated contraction by Rho kinase inhibitor fasudil in rabbit aorta. DPB, MBS, PKC
35  2003 Differential signalling by muscarinic receptors in smooth muscle: m2-mediated inactivation of myosin light chain kinase via Gi3, Cdc42/Rac1 and p21-activated kinase 1 pathway, and m3-mediated MLC20 (20 kDa regulatory light chain of myosin II) phosphorylation via Rho-associated kinase/myosin phosphatase targeting subunit 1 and protein kinase C/CPI-17 pathway. MLCK, PAK1, PKC, Rho-kinase
36  2002 Rho-kinase inhibition blunts renal vasoconstriction induced by distinct signaling pathways in vivo. CPA, GBF, MLC, ROK